Cargando...
Patient preference for second and third line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study
Patient preference is key for medication selection in chronic medical conditions, like type 2 diabetes, where there are many different drugs available. Patient preference balances potential efficacy with potential side effects. As both aspects of drug response can vary markedly between individuals t...
Gardado en:
| Publicado en: | Nat Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2023
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7614215/ https://ncbi.nlm.nih.gov/pubmed/36477734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-022-02121-6 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|